| Literature DB >> 33997083 |
Yoichi Murata1, Naomasa Fukase1, Maitland Martin1, Rui Soares1, Lauren Pierpoint1, Grant J Dornan1, Soshi Uchida2, Marc J Philippon1.
Abstract
BACKGROUND: The treatment for borderline developmental dysplasia of the hip (BDDH) has historically been arthroscopic surgery or periacetabular osteotomy (PAO). As orthopaedic surgery is constantly evolving, a lack of comparison of outcomes for these 2 treatment methods could potentially be stalling the progression of treatment for patients with BDDH.Entities:
Keywords: borderline developmental dysplasia of the hip (BDDH); hip arthroscopic surgery; periacetabular osteotomy (PAO); systematic review
Year: 2021 PMID: 33997083 PMCID: PMC8113971 DOI: 10.1177/23259671211007401
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Inclusion and Exclusion Criteria
| Inclusion Criteria | Exclusion Criteria |
|---|---|
|
Patients of all ages and sexes Reporting the surgical outcomes of isolated hip procedures Patients having the diagnosis of borderline hip dysplasia |
Review articles Diagnostic studies Case reports Technique reports Opinion articles Written in a language other than English Patients with other hip deformities, such as acetabular fractures, Legg-Calve-Perthes disease, inflammatory hip disorders, global morphological abnormalities requiring surgical dislocation, and generalized focal or neuromuscular disorders Articles that seem to involve overlapping patients |
Institution, Overlapping Authors, and Extraction Period of Included Studies
| First author (Year) | Institution | Overlapping Authors | Extraction Period |
|---|---|---|---|
| Beck[ | Department of Orthopaedic Surgery, Rush University Medical Center | None | 1/2012 to 1/2017 |
| Chaharbakhshi[ | American Hip Institute | Domb, Perets | 4/2010 to 11/2014 |
| Chaharbakhshi[ | American Hip Institute | Domb, Perets | 2/2008 to 4/2014 |
| Chandrasekaran[ | American Hip Institute and Hinsdale Orthopaedics | Domb | 4/2008 to 4/2013 |
| Cvetanovich[ | Rush University Medical Center | None | 1/2012 to 1/2014 |
| Domb[ | American Hip Institute and Hinsdale Orthopaedics | Chaharbakhshi, Perets | 2/2008 to 12/2010 |
| Domb[ | American Hip Institute and Hinsdale Orthopaedics | None | 4/2008 to 11/2010 |
| Evans[ | Larner College of Medicine, University of Vermont; Southeast Orthopedic Specialists; University of Illinois College of Medicine; Pritzker School of Medicine, University of Chicago; Stritch School of Medicine, Loyola University Chicago; and American Hip Institute | Chaharbakhshi, Domb | 1/2008 to 1/2013 |
| Fukui[ | Steadman Philippon Research Institute | None | 6/2005 to 3/2011 |
| Hatakeyama[ | Wakamatsu Hospital, University of Occupational and Environmental Health | None | 3/2009 to 12/2014 |
| Maldonado[ | American Hip Institute | Domb, Perets | 11/2008 to 1/2015 |
| Nawabi[ | Hospital for Special Surgery | None | 3/2009 to 7/2012 |
| Yoon[ | Department of Orthopedic Surgery, Jeonbuk National University Medical School | None | 3/2015 to 12/2017 |
| McClincy[ | Child and Young Adult Hip Preservation Program, Department of Orthopedic Surgery, Boston Children’s Hospital | None | 1/2010 to 12/2014 |
| Mose[ | Department of Orthopedics, School of Medical Sciences, Örebro University | None | 1/2010 to 8/2011 |
Chaharbakhshi et al[6] (2019) and Chandrasekaran et al[8] (2017) were excluded because the authors were affiliated with the same institution as Chaharbakhshi et al[7] (2017) and had a shorter duration of inclusion.
Domb et al[16] (2013) was excluded because the authors were affiliated with the same institution as those of Domb et al[14] (2018) and had shorter follow up from an older period (i.e. less recent results).
Evans et al[17] (2017) was included because more institutions other than the American Hip Institute were involved; this could have been a result of multisite research and, therefore, a multisite patient population. Additionally, this study involved a younger patient population (<18 years); again, more likely there was less overlap, as no other included study had this inclusion/exclusion criterion.
Maldonado et al[27] (2018) was included because it had different and more precise inclusion/exclusion criteria than did the other studies included; this could also have minimized patient overlap before publication, and thus, this article was included.
Figure 1.PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart of the search strategy. DDH, developmental dysplasia of the hip; MRI, magnetic resonance imaging; ROM, range of motion.
Characteristics of Included Studies
| First author (Year) | Study Type (LOE) | Definition of BDDH | No. of Patients | Mean Age, y | Mean ± SD Follow-up, mo | Outcome Measures |
|---|---|---|---|---|---|---|
| Hip arthroscopic surgery | ||||||
| Beck[ | Cohort (3) | LCEA, 20°-25° | 112 | 33.6 ± 12.7 | 24 | mHHS, HOS-ADL, HOS-SSS, iHOT-12 |
| Chaharbakhshi[ | Cohort (3) | LCEA, 18°-25° | 40 | LT tear: 29.6 ± 12.2; no LT tear: 26.8 ± 11.5 | 54.3 | mHHS, NAHS, HOS-SSS, VAS pain, satisfaction |
| Cvetanovich[ | Cohort (3) | LCEA, 18°-25° | 36 | 31.5 ± 11.8 | 31.2 ± 7.2 | mHHS, HOS-SSS, HOS-ADL, satisfaction |
| Domb[ | Case series (4) | LCEA, 18°-25° | 19 (21 hips) | 22.9 | 68.8 ± 6.4 | mHHS, NAHS, HOS-SSS, VAS pain, satisfaction |
| Evans[ | Therapeutic (4) | LCEA, 20°-25° | 21 | 15.5 | 26.3 | mHHS, NAHS, HOS-SSS, HOS-ADL, VAS pain, satisfaction |
| Fukui[ | Therapeutic (4) | LCEA, 20°-25° | 102 | 35 | 40 | mHHS, HOS-ADL, HOS-SSS, SF-12 PCS, SF-12 MCS, WOMAC, satisfaction |
| Hatakeyama[ | Case-control (3) | LCEA, 20°-25° | 45 | 31.4 | 42.5 | mHHS, NAHS |
| Maldonado[ | Case-control (3) | LCEA, 18°-25° | 115 (122 hips) | Success: 23.5 ± 7.5; failure: 28.5 ± 7.8 | Success: 39.2 ± 17.3; failure: 42.8 ± 20.4 | mHHS, NAHS, HOS-SSS, VAS pain, satisfaction |
| Nawabi[ | Cohort (3) | LCEA, 18°-25° | 46 (55 hips) | 29.8 ± 9.4 | 31.3 ± 7.6 | mHHS, HOS-SSS, HOS-ADL, iHOT-33, satisfaction |
| Yoon[ | Therapeutic (4) | LCEA, 20°-25° | 45 (47 hips) | 39.2 ± 11.8 | 25.9 | mHHS, NAHS, VAS pain, satisfaction |
| PAO | ||||||
| McClincy[ | Therapeutic (4) | LCEA, 18°-25° | 49 | 26.5 ± 8 | 26.4 | mHHS, UCLA, HOOS, SF-12 |
| Mose[ | Cohort (3) | LCEA, 20°-25° | 44 | 34.1 | 24 | WOMAC, OHS, SF-36 |
BDDH, borderline developmental dysplasia of the hip; HOOS, Hip disability and Osteoarthritis Outcome Score; HOS-ADL, Hip Outcome Score–Activities of Daily Living; HOS-SSS, Hip Outcome Score–Sport-Specific Subscale; iHOT-12, 12-Item International Hip Outcome Tool; iHOT-33, 33-Item International Hip Outcome Tool; LCEA, lateral center-edge angle; LOE, level of evidence; LT, ligamentum teres; MCS, Mental Component Summary; mHHS, modified Harris Hip Score; NAHS, Nonarthritic Hip Score; OHS, Oxford Hip Score; PAO, periacetabular osteotomy; PCS, Physical Component Summary; SF-12, 12-Item Short Form Health Survey; SF-36, 36-Item Short Form Health Survey; UCLA, University of California, Los Angeles; VAS, visual analog scale; WOMAC, Western Ontario and McMaster Universities Arthritis Index.
The patients with LT tears were matched in a 1:1 ratio to patients without LT tears based on the following criteria: sex, age at surgery ±10 years, obesity (body mass index <30 vs ≥30), labral treatment type (repair vs selective debridement), and microfracture.
The “success” group consisted of all patients who achieved the Patient Acceptable Symptom State (PASS) of an mHHS score ≥74 and underwent no ipsilateral hip surgery subsequent to their index arthroscopic surgery. The “failure” group was composed of patients who did not achieve the PASS at latest follow-up or required secondary arthroscopic surgery or conversion to total hip arthroplasty.
Coleman Methodology Scores of Included Studies
| First author (Year) | Category | Total Score (of 100) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
| Hip arthroscopic surgery | ||||||||||||
| Beck[ | 10 | 0 | 5 | 10 | 0 | 5 | 5 | 5 | 10 | 6 | 15 | 71 |
| Chaharbakhshi[ | 4 | 3 | 5 | 10 | 0 | 5 | 3 | 3 | 10 | 6 | 15 | 64 |
| Cvetanovich[ | 10 | 0 | 3 | 10 | 0 | 5 | 5 | 3 | 10 | 6 | 15 | 67 |
| Domb[ | 0 | 3 | 3 | 10 | 0 | 5 | 3 | 3 | 10 | 11 | 15 | 63 |
| Evans[ | 4 | 0 | 3 | 10 | 0 | 5 | 5 | 3 | 10 | 6 | 15 | 61 |
| Fukui[ | 7 | 3 | 3 | 10 | 0 | 5 | 5 | 3 | 10 | 6 | 15 | 67 |
| Hatakeyama[ | 4 | 0 | 5 | 10 | 0 | 5 | 5 | 3 | 10 | 15 | 15 | 72 |
| Maldonado[ | 7 | 0 | 0 | 10 | 0 | 5 | 3 | 0 | 10 | 6 | 10 | 51 |
| Nawabi[ | 10 | 0 | 0 | 10 | 0 | 5 | 5 | 0 | 10 | 6 | 15 | 61 |
| Yoon[ | 4 | 0 | 0 | 10 | 0 | 5 | 5 | 0 | 10 | 11 | 10 | 55 |
| PAO | ||||||||||||
| McClincy[ | 4 | 0 | 3 | 5 | 0 | 5 | 3 | 0 | 7 | 6 | 5 | 38 |
| Mose[ | 7 | 0 | 5 | 10 | 10 | 5 | 0 | 0 | 10 | 6 | 10 | 63 |
PAO, periacetabular osteotomy.
1 = study size; 2 = mean follow-up; 3 = percentage of patients with follow-up; 4 = number of interventions per group; 5 = study type; 6 = diagnostic certainty; 7 = description of surgical technique; 8 = description of postoperative rehabilitation; 9 = outcome criteria; 10 = procedure for assessing outcomes; 11 = description of participant selection process.
Arthroscopic Procedures of Included Studies
| Beck[ | Chaharbakhshi[ | Cvetanovich[ | Domb[ | Evans[ | Fukui[ | Hatakeyama[ | Maldonado[ | Nawabi[ | Yoon[ | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of hips | 112 | LT tear: 20 | No LT tear: 20 | 36 | 21 | 21 | 102 | 45 | Success: 97 | Failure: 25 | 55 | 47 |
| Acetabular chondroplasty | NR | NR | NR | NR | 6 (29) | 0 (0) | 18 (18) | NR | NR | NR | NR | NR |
| Acetabular decortication | NR | 7 (35) | 8 (40) | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Acetabular rim trimming | 95 (85) | NR | NR | 4 (11) | NR | NR | 5 (5) | NR | NR | NR | NR | NR |
| Acetabuloplasty | NR | NR | NR | NR | NR | NR | NR | NR | 43 (44) | 12 (48) | NR | NR |
| Cam and rim decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 5 (9) | NR |
| Cam and subspinal decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 25 (46) | NR |
| Cam decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 54 (98) | NR |
| Cam, rim, and subspinal decompression | NR | NR | NR | NR | NR | NR | 80 (78) | NR | NR | NR | 10 (18) | NR |
| Capsular closure | 112 (100) | NR | NR | 36 (100) | NR | NR | 102 (100) | NR | NR | NR | 55 (100) | NR |
| Capsular plication | NR | 20 (100) | 20 (100) | NR | 21 (100) | 21 (100) | 38 (37) | 45 (100) | 97 (100) | 25 (100) | NR | 15 (32) |
| Capsular shift | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 3 (6) | NR |
| Femoroplasty | 112 (100) | 12 (60) | 16 (80) | 36 (100) | 11 (52) | 15 (71) | 17 (17) | 42 (93) | 79 (81) | 20 (80) | NR | NR |
| Iliopsoas bursectomy | NR | NR | NR | NR | 1 (5) | 3 (14) | NR | NR | NR | NR | NR | NR |
| Iliopsoas fractional lengthening | NR | 9 (45) | 9 (45) | NR | 11 (52) | NR | NR | NR | 67 (69) | 17 (68) | NR | NR |
| Iliopsoas release | NR | NR | NR | 0 (0) | NR | 15 (71) | NR | NR | NR | NR | NR | NR |
| Isolated cam decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 14 (26) | NR |
| Iliotibial band release | NR | NR | NR | 1 (3) | NR | NR | NR | NR | NR | NR | NR | NR |
| Labral debridement | NR | 7 (35) | 7 (35) | NR | 1 (5) | 8 (38) | NR | NR | 20 (21) | 6 (24) | 17 (31) | 3 (6) |
| Labral reconstruction | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Labral repair | 112 (100) | 13 (65) | 13 (65) | 32 (89) | 20 (95) | 13 (62) | 102 (100) | 42 (93) | 76 (78) | 17 (68) | 38 (69) | 12 (26) |
| LT debridement | NR | 20 (100) | 0 (0) | NR | 12 (57) | 3 (14) | 95 (93) | NR | NR | NR | 13 (24) | 9 (19) |
| Microfracture | NR | 1 (5) | 1 (5) | 0 (0) | NR | NR | NR | NR | 5 (5) | 1 (4) | NR | NR |
| Notchplasty | NR | 0 (0) | 1 (5) | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Osteochondroplasty | NR | NR | NR | NR | NR | NR | 4 (4) | 42 (93) | NR | NR | 40 (73) | NR |
| Rim decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 15 (27) | NR |
| Rim trimming | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Subspinal decompression | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 35 (64) | NR |
| Synovectomy | NR | 0 (0) | 2 (10) | NR | NR | 3 (14) | NR | NR | NR | NR | NR | 3 (6) |
| Trochanteric bursectomy | NR | NR | NR | 1 (3) | NR | NR | NR | NR | 2 (2) | 2 (8) | NR | NR |
This study reported values for both “cam decompression” and “isolated cam decompression.” As there was no explanation for the distinction(s) between the two accessory procedures, both were recorded for the purpose of this review. Studies are presented as first author (year). Values are presented as n (%). LT, ligamentum teres; NR, not reported.
Patient-Reported Outcome Scores of Included Studies: Hip Arthroscopic Surgery
| First author (Year) | mHHS | HOS-ADL | HOS-SSS | NAHS | VAS Pain | Satisfaction | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | ||
| Beck[ | 55.6 ± 14.5 | 78.6 ± 17.1 | 63.8 ± 18.7 | 85.5 ± 17.4 | 41.7 ± 20.5 | 72.6 ± 27.1 | NR | NR | 67.2 ± 18.3 | 18.9 ± 21.5 | 77.1 ± 28.5 |
| Chaharbakhshi[ | LT tear: 64.1 ± 13.5; no LT tear: 66.9 ± 14.3 | LT tear: 81.3 ± 13.7; no LT tear: 87.4 ± 8.9 | NR | NR | LT tear: 44.1 ± 22.8; no LT tear: 50.4 ± 23.9 | LT tear: 68.1 ± 28.9; no LT tear: 75.6 ± 19.6 | LT tear: 63.9 ± 16.2; no LT tear: 67.7 ± 15.4 | LT tear: 81.7 ± 13.9; no LT tear: 88.4 ± 8.9 | LT tear: 5.3 ± 2.6; 5.5 ± 1.9 | LT tear: 2.7 ± 2.5; no LT tear: 2.1 ± 2.1 | LT tear: 8.1; no LT tear: 7.9 |
| Cvetanovich[ | 57.2 ± 12.3 | 79.9 ± 13.8 | 65.4 ± 16.0 | 88.6 ± 15.2 | 44.5 ± 20.9 | 73.6 ± 26.7 | NR | NR | 7.6 ± 2.4 | 1.4 ± 1.6 | 81.1 ± 22.3 |
| Domb[ | 70.3 ± 9.8 | 85.9 ± 12.1 | NR | NR | 52.1 ± 15.9 | 70.8 ± 19.5 | 68.3 ± 13.2 | 87.3 ± 9.8 | 5.6 ± 2.5 | 1.8 ± 1.3 | 7.9 ± 1.7 |
| Evans[ | 59.71 | 88.04 | 62.91 | 94.74 | 42.13 | 81.59 | 62.75 | 91.94 | 6.29 | 1.31 | 7.89 |
| Fukui[ | 63.5 ± 14 | 84.9 ± 14 | 70.9 ± 13 | 84.7 ± 17 | 51.4 ± 22 | 75.7 ± 25 | NR | NR | NR | NR | 8 |
| Hatakeyama[ | Success: 72.1; failure: 68.1 | 100 | NR | NR | NR | NR | Success: 72.1; failure: 68.1 | 98.8 | NR | NR | NR |
| Maldonado[ | 65.4 ± 16.1 | 90.9 ± 7.6 | NR | NR | 45.1 ± 24.8 | 84.7 ± 15.6 | 64.6 ± 18.0 | 90.9 ± 7.6 | 5.2 ± 2.4 | 1.4 ± 1.7 | 8.5 ± 1.7 |
| Nawabi[ | 61.7 ± 10.9 | 86.2 ± 14.6 | 76 ± 14.4 | 93.2 ± 11.3 | 54.6 ± 23 | 85.4 ± 22.1 | NR | NR | NR | NR | NR |
| Yoon[ | 61.0 ± 7.6 | 78.6 ± 19.5 | NR | NR | NR | NR | 62.1 ± 7.5 | 80.0 ± 18.5 | 6.1 ± 1.6 | 3.5 ± 2.8 | NR |
Values are presented as mean ± SD. HOS-ADL, Hip Outcome Score–Activities of Daily Living; HOS-SSS, Hip Outcome Score–Sport-Specific Subscale; LT, ligamentum teres; mHHS, modified Harris Hip Score; NAHS, Nonarthritic Hip Score; NR, not reported; VAS, visual analog scale.
Patient-Reported Outcome Scores of Included Studies: PAO
| First author (Year) | Preoperative | Postoperative |
|---|---|---|
| McClincy[ | ||
| mHHS | 64 ± 19 | 86 ± 13 |
| HOOS Pain | 52 ± 23 | 78 ± 25 |
| HOOS Symptoms | 58 ± 22 | 76 ± 22 |
| HOOS Activities of Daily Living | 69 ± 23 | 87 ± 22 |
| HOOS Sport/Recreation | 47 ± 29 | 76 ± 26 |
| HOOS Quality of Life | 32 ± 24 | 66 ± 28 |
| HOOS total | 261 ± 117 | 386 ± 128 |
| SF-12 PCS | 39 ± 12 | 47 ± 11 |
| SF-12 MCS | 51 ± 11 | 52 ± 8 |
| UCLA | 6 ± 2 | 7 ± 2 |
| Mose[ | ||
| WOMAC total | 69 (57-80) | 90 (78-99) |
| WOMAC pain | 13 (11-15) | 16 (14-20) |
| OHS | 31 (27-35) | 40 (30-47) |
| SF-36 PCS | 38.9 ± 7.9 | 45.5 ± 12.2 |
| SF-36 MCS | 49.5 ± 10.4 | 53.4 ± 10.7 |
Values are presented as mean ± SD or median (interquartile range). HOOS, Hip disability and Osteoarthritis Outcome Score; MCS, Mental Component Summary; mHHS, modified Harris Hip Score; OHS, Oxford Hip Score; PAO, periacetabular osteotomy; PCS, Physical Component Summary; SF-12, 12-Item Short Form Health Survey; SF-36, 36-Item Short Form Health Survey; UCLA, University of California, Los Angeles; WOMAC, Western Ontario and McMaster Universities Arthritis Index.
Failure Rate of Included Studies: Hip Arthroscopic Surgery
| First author (Year) | Follow-up, | No. of Hips | Revision Hip Arthroscopic Surgery | Conversion to THA | ||
|---|---|---|---|---|---|---|
| n (%) | Description | n (%) | Description | |||
| Beck[ | 24 | 112 | 1 (0.9) | NR | 1 (0.9) | NR |
| Chaharbakhshi[ | 54.3 (24.2-83.8) | LT tear: 20; no LT tear: 20 | LT tear: 5 (25.0); no LT tear: 1 (5.0) | The mean time to revision was 22.9 mo (range, 4.1-48.1 mo). One case of revision consisted of loose body removal and recurrent LT debridement for partial tearing. There were 2 patients who each required 2 revisions: (1) One of these patients underwent revision arthroscopic surgery at 7.1 and 47.9 mo from the index arthroscopic procedure and ultimately underwent THA. (2) The remaining 2 revisions in the LT tear group were performed in 1 patient at 7.1 and 48.1 mo for recurrent chondral defects and labral tearing. One patient in the control group underwent revision at 1.8 mo from the index procedure for an underresected femoral neck deformity and recurrent labral tearing, which resulted in the alleviation of symptoms. | LT tear: 3 (15.0); no LT tear: 0 (0.0) |
|
| Cvetanovich[ | 31.2 ± 7.2 | 36 | 1 (2.8) | NR | 0 (0.0) | NR |
| Domb[ | 68.8 ± 6.4 (60.0-93.8) | 21 | 4 (19.0) | The mean time to revision was 25.1 ± 19.2 mo (range, 4.1-50.1 mo). There were 2 hips that underwent loose body removal, 1 of which was for heterotopic ossification measuring >5 mm and the other was for residual suture material related to a rupture from previous capsular plication. All patients were noted to have improvements in PRO scores at a mean of 42.3 mo after revision. | 0 (0.0) | NR |
| Evans[ | 26.3 | 21 | 0 (0.0) | NR | 0 (0.0) | NR |
| Fukui[ | 40 (24-97) | 80 | 7 (8.8) |
| 5 (6.3) | There were 4 men and 1 woman with a mean age of 42 y at a mean of 2 y (range, 11-48 mo) after arthroscopic surgery. |
| Hatakeyama[ | 42.5 (24.0-72.6) | 45 | 7 (15.6) | There were 2 patients who underwent revision arthroscopic surgery (trimming for osteophytes at the cotyloid fossa, labral repair, cam osteochondroplasty, and microfracture at the acetabulum) because of the progression of OA and labral retearing, and 5 underwent arthroscopic shelf acetabuloplasty. | 2 (4.4) | THA performed because of progressive OA with lateral migration of the femoral head. |
| Maldonado[ | Success: 39.2 ± 17.3; failure: 42.8 ± 20.4 | 122 | NR | NR | NR | NR |
| Nawabi[ | 31.3 ± 7.6 (23.1-67.3) | 46 | 2 (4.3) | At a mean of 9.6 and 23.8 mo after arthroscopic surgery, 1 patient underwent revision for painful adhesions, and 1 patient underwent it for recurrent labral tearing, respectively. | 0 (0.0) | NR |
| Yoon[ | 25.9 | 47 | NR | NR | NR | NR |
ALAD, acetabular labrum articular disruption; BMI, body mass index; LT, ligamentum teres; NR, not reported; OA, osteoarthritis; PRO, patient-reported outcome; THA, total hip arthroplasty.
Values are presented as mean ± SD (and range, if shown).
Failure Rate of Included Studies: PAO
| First author (Year) | Mean Follow-up, mo | No. of Patients | Revision Hip Arthroscopic Surgery | Conversion to THA | ||
|---|---|---|---|---|---|---|
| n (%) | Description | n (%) | Description | |||
| McClincy[ | 26.4 | 49 | NR | NR | NR | NR |
| Mose[ | 24 | 99 | 22 (22.2) | There were 14 patients with type 3a tears, 1 patient with a type 3b tear, and 1 patient with a type 1 tear. Also, 4 patients were preoperatively classified as having type 0 tears, but during arthroscopic surgery, the labrum was found to be affected in 3 patients and was treated accordingly. | 1 (1.0) | NR |
NR, not reported; PAO, periacetabular osteotomy; THA, total hip arthroplasty.
There were 44 patients with borderline dysplasia (lateral center-edge angle of 20°-25°) and 55 with dysplasia (lateral center-edge angle <20°), which we could not distinguish.